Health
-
Why it seems like everyone has the flu this year
Immunologist says it’s not too late to get vaccinated
-
AI is speeding into healthcare. Who should regulate it?
Medical ethicist details need to balance thoughtful limits while avoiding unnecessary hurdles as industry groups issue guidelines
-
How to get stronger
If you’re not failing all the time, you’re doing it wrong, says fitness expert
Part of the Wondering series -
Real-world answers for patients running out of time
Insurance data can help fill gaps between longer trials, researchers say
-
Binge drinking triggers gut damage, finds new study
Research suggests even brief episodes of heavy alcohol consumption can injure small intestine
-
Sports betting worries grow as wagers skyrocket
Experts see rise in gambling problems, possible wider cultural fallout
-
When pollinator populations are in peril
New Harvard study finds pollination loss removes healthy foods from global diets, increases chronic diseases causing an estimated 427,000 excess deaths annually.
-
Eating more during the holidays? Don’t mistake Oreo calories for olive calories.
David Ludwig discusses the drivers of the country’s obesity crisis and how more people can maintain a healthy weight.
-
N.Y. plan to involuntarily treat mentally ill homeless? Not entirely outrageous.
Katherine Koh, a street psychiatrist at Mass. General Hospital, explains the complicating factors behind New York City’s proposal to involuntarily treat mentally ill homeless people.
-
Severe COVID-19 linked with brain aging
Researchers have linked the molecular signatures underlying brain aging with the cognitive decline observed in patients with severe COVID-19.
-
‘What kind of husband could stand by idly for four years while his wife’s breast cancer grew?’
Barrett Rollins, wife Jane Weeks were Dana-Farber stars who kept her cancer secret nearly to end
-
DASH diet’s impact differs based on race and gender
A new study shows that the Dietary Approaches to Stop Hypertension (DASH) diet reduces the risk of cardiovascular disease, especially for women and Black adults.
-
New CDC guidelines a ‘corrective’ for opioid prescriptions, specialist says
The CDC updates its 2016 opioid prescribing guidelines, to emphasize flexibility over rigid practices and laws whose aim is to reduce addiction.
-
Knowing what the doctor knows
Tom Delbanco explains why he supports giving patients greater access to records
-
Alcohol, sleep, and politics
A new BIDMC study suggests that divisive political events like elections can negatively affect one’s sleep and emotional well-being.
-
New AI tool can predict melanoma recurrence
A new AI tool may help clinicians determine which early stage melanoma patients would likely benefit from aggressive treatment even at the onset of the disease.
-
When our cells turn against us
Cells are the building blocks of life, Siddhartha Mukherjee says in his new book, but their vulnerabilities are also our vulnerabilities.
-
Study details better outcomes for Omicron BA.2 patients
A team led by investigators at Massachusetts General Hospital has determined that Omicron BA.2 is weaker than both Delta and the original Omicron variant.
-
Siddhartha Mukherjee on Aristotle, COVID, and the ‘new human’
Pulitzer Prize-winning physician-author Siddhartha Mukherjee returns with “The Song of the Cell.”
-
Is pandemic finally over? We asked the experts.
Harvard faculty discuss changes to views on school, work, winter’s likely surge, danger of “lethal inflexibility.”
-
Building ‘bravery muscles’ to fight rising anxiety among kids
Harvard psychologist says pandemic worsened trend and screening, early intervention key to avoiding bigger problems.
-
Late-night eating and weight gain
A new study explains that when we eat significantly impacts our energy expenditure, appetite, and molecular pathways in body fat.
-
What makes us human? It’s all in the hips
Study shows how pelvis takes shape and what genes orchestrate the process.
-
Parents are so wrong about teenage sleep and health
Harvard-affiliated study upends common myths around melatonin, weekends, school start times.
-
Forget the sedatives, I’ll take some VR
Study of hand-surgery patients suggests “immersive experience” can curb need for drugs, cut hospital stay.
-
Why are young people so miserable?
A Harvard-led study examining measures of well-being showed younger adults had the lowest scores of any age group.
-
Breast cancer findings ‘suggest a new set of criteria for avoiding radiation’
Emerging research suggests following surgery with medication may produce similar results for patients as young as 55.
-
Restricted airways, scarred lung tissue found among vapers
Study is first to microscopically evaluate the pulmonary tissue of e-cigarette users for chronic disease.
-
Dramatic rise in cancer in people under 50
Altered microbiome, lack of sleep seen as possible culprits in 30-year global increase among under-50 adults
-
How to reduce health risks from a gas stove
If you have a gas stove taking a few steps can help protect your household.
-
Nurse practitioners fill care gaps amid surge in mental health demand
As demand for mental health care soars, nurse practitioners help offset drop in psychiatrists accepting insurance, study finds.
-
Psychological, not physical factors linked to long COVID
Depression, anxiety, worry, perceived stress, and loneliness measured before infection with COVID-19 were associated with up to 45 percent increased risk of developing long COVID.
-
Demystifying Parkinson’s
Vikram Khurana discussed recent advances and new, individualized approaches to Parkinson’s, as well as implications of the recent findings.
-
Study reveals fentanyl’s effects on the brain
Researchers have learned that fentanyl produces a specific EEG signature, which could allow clinicians to monitor its effects to enable safer, more personalized administration during and after surgery.
-
Being good for goodness’ sake — and your own
A Harvard Chan School study associated high moral character with lower depression risk as well as potential cardio benefits.
-
Diabetes drugs may reduce cardiovascular deaths
Drugs originally developed for the treatment of Type 2 diabetes were found to reduce cardiovascular deaths and heart failure events among patients.